September 13, 2018 | Washington, DC

CHILDHOOD CANCER HEARING LOSS

 
 

an externally-led Patient-Focused Drug Development Workshop:

chemotherapy-induced hearing loss

in pediatric oncology

 
 
senjuti-kundu-349558-unsplash.jpg
 

meeting details

 

 September 13, 2018 -- 1:00-5:00 pm

College Park Marriott Hotel & Conference Center in Hyattsville, MD

view the webcast recording here.


meeting objectives:

The half-day meeting followed the FDA model for externally-led PFDD meetings and featured a series of facilitated panel and audience discussions, and a webinar with live polling focused on providing the FDA and other stakeholders with patient views on key issues such as:

  • Burden of the condition (physical, emotional, financial issues) impacting daily health-related quality of life;

  • Assessments of current and potential future treatments;

  • Benefits that patients with chemotherapy-induced hearing loss are looking for in treatments and the risks they are willing to assume in return for more advanced interventions;

  • Participation in clinical trials and ideas on trial design to make them more appealing to people with chemotherapy-induced hearing loss.

 
 
 
 
 
 
DC_PFDD website (2).png